Keywords: مولتیپل میلوما; HIV; Autologous transplantation; Non-Hodgkin lymphoma; Multiple myeloma;
مقالات ISI مولتیپل میلوما (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مولتیپل میلوما; Multiple myeloma; Serum free light chain ratio; Lactic dehydrogenase; Prognosis; Risk stratification;
Keywords: مولتیپل میلوما; AE; adverse event; ADR; adverse drug reaction; ANC; absolute neutrophil count; CI; confidence interval; CR; complete remission; CTCAE; common terminology criteria for adverse events; DEX; dexamethasone; ECOG; eastern cooperative oncology group; eCRF; elec
Keywords: مولتیپل میلوما; Multiple myeloma; Allogeneic transplantation; Novel agents; Graft-versus-myeloma effect;
Keywords: مولتیپل میلوما; antibodies, monoclonal; deacetylase inhibitors, histone; inhibitors; proteasome; meta-analysis as topic; multiple myeloma; therapies, immunomodulatory;
Keywords: مولتیپل میلوما; Monoclonal gammopathy of undetermined significance; Smoldering multiple myeloma; Multiple myeloma; Protein electrophoresis; Immunofixation; Free light chain assays; Heavy/light chain assays; M-spike; M-protein follow-up;
Keywords: مولتیپل میلوما; BTZ; bortezomib; CFZ; carfilzomib; C-L; caspase-like; CNS; central nervous system; CT-L; chymotrypsin-like; CYPs; cytochrome P450 enzymes; iP; immunoproteasome; IXZ; ixazomib; MM; multiple myeloma; OPZ; oprozomib; PD; pharmacodynamic; PI; proteasome inhib
Keywords: مولتیپل میلوما; AE; Adverse event; BIPN; Bortezomib-induced peripheral neuropathy; C-L; Caspase-like; CFZ; Carfilzomib; ChT-L; Chymotrypsin-like action; IRd; Ixazomib, lenalidomide, and dexamethasone; LG; Leaving group; MM; Multiple myeloma; MTD; Maximum tolerated dose;
Keywords: مولتیپل میلوما; Hematopoietic cell transplantation; Hematopoietic progenitor cell mobilization; Multiple myeloma;
Keywords: مولتیپل میلوما; proteasome inhibitors; multiple myeloma; bortezomib; ubiquitin-proteasome pathway;
Keywords: مولتیپل میلوما; Multiple myeloma; Chemotherapy; Elderly;
Keywords: مولتیپل میلوما; Kidney allograft rejection; lenalidomide; multiple myeloma; kidney transplant; acute renal allograft rejection; immunomodulatory chemotherapy agent; chemotherapy regimen; malignancy; immunosuppression withdrawal; case report;
Keywords: مولتیپل میلوما; Kidney transplantation; multiple myeloma; autologous stem cell transplantation (ASCT); outcomes; end-stage renal disease (ESRD); kidney failure; renal replacement therapy (RRT); RRT modality; hematologic malignancy; light chain deposition disease (LCDD);
Keywords: مولتیپل میلوما; Systemic mastocytosis; Multiple myeloma; Associated hematological neoplasms; Treatment; Prognosis;
Keywords: مولتیپل میلوما; Plasmacytoma; Multiple Myeloma; Bone Neoplasms; Neoplasms, Plasma Cell;
Keywords: مولتیپل میلوما; iksazomib; szpiczak plazmocytowy; leczenie; Ixazomib; Multiple Myeloma; Treatment;
Keywords: مولتیپل میلوما; B-CLPD; B-cell chronic lymphoproliferative disorders; BM; bone marrow; CONT; contaminated group; FCM; flow-cytometry; GC; good-quality group; MGUS; Monoclonal gammopathy of undetermined significance; MM; Multiple myeloma; MRD; minimal residual disease; PB
Keywords: مولتیپل میلوما; Multiple myeloma; Autologous stem cell transplantation; Outpatient transplantation; Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI);
Keywords: مولتیپل میلوما; Multiple myeloma; Differentially expressed genes; Area under the curve; Pathway cross-talk; Monte Carlo cross-validation;
Keywords: مولتیپل میلوما; Multiple myeloma; Antitumor reagent; Natural product;
Keywords: مولتیپل میلوما; AL amyloidosis; Restrictive cardiomyopathy; Multiple myeloma; Heart failure;
Keywords: مولتیپل میلوما; Abnormal protein band; Oligoclonal bands; Multiple myeloma; Prognosis;
Keywords: مولتیپل میلوما; γc; common gamma chain, CD132; IL; interleukin; sγc; soluble form of common gamma chain; JAK; Janus-activated kinase; STAT; signal transducer and activator of transcription; T-ALL; T-cell acute lymphocytic leukemia; B-ALL; B-cell acute lymphocytic leuke
Keywords: مولتیپل میلوما; Multiple myeloma; Haploidentical; Post-transplantation cyclophosphamide;
Keywords: مولتیپل میلوما; Multiple myeloma; Aspirin; Analgesics; Neoplasms; Meta-analysis;
Keywords: مولتیپل میلوما; multiple myeloma; monoclonal antibodies; elotuzumab; daratumumab;
Keywords: مولتیپل میلوما; Peripheral blood stem cells; Cryopreservation; Long-term storage; Autologous blood stem cell transplantation; Multiple myeloma;
Keywords: مولتیپل میلوما; Metastases; Multiple myeloma; Subdural hemorrhage; Diagnostic pitfall;
Keywords: مولتیپل میلوما; Carfilzomib; Proteasome inhibitors; Multiple myeloma; Coronary resistance; Vascular tone;
Keywords: مولتیپل میلوما; Proteasome inhibitors; Heart failure; Myocardium; Multiple myeloma;
Keywords: مولتیپل میلوما; Multiple myeloma; Transplant eligible patients; First relapse; Autologous stem cell transplantation; New agents; Treatment; Multiple myeloma; Transplant eligible patients; First relapse; Autologous stem cell transplantation; New agents; Treatment;
Keywords: مولتیپل میلوما; Multiple myeloma; Histone deacetylase inhibitors; Epigenetic modification;
Keywords: مولتیپل میلوما; Autologous stem cell transplantation; Differential scanning calorimetry; Immunological biomarkers; Monoclonal immunoglobulins; Multiple myeloma;
Keywords: مولتیپل میلوما; Amyloidosis; Kidney; Multiple myeloma;
Keywords: مولتیپل میلوما; Multiple myeloma; Acute myeloid leukemia; Transplant; Elderly; Geriatric assessment; Autologous; Allogeneic;
Keywords: مولتیپل میلوما; Cardiac amyloidosis; Multiple myeloma; TTR; Cardiotoxicity; Proteasome inhibitors; Immunomodulatory drugs;
Keywords: مولتیپل میلوما; Multiple myeloma; High-risk cytogenetics; Minimal residual disease; Autologous stem cell transplantation;
Keywords: مولتیپل میلوما; Multiple myeloma; Acute myeloid leukemia; Transplant; Elderly; Geriatric assessment; Autologous; Allogeneic;
Keywords: مولتیپل میلوما; Multiple myeloma; CTD; VCD;
Keywords: مولتیپل میلوما; Multiple myeloma; Pharmacologically-dosed ascorbic acid; Apoptosis-inducing factor 1; MM; multiple myeloma; ROS; reactive oxygen species; SMM; smoldering MM; IMIDs; immunomodulatory drugs; ASCT; autologous stem cell transplantation; CRs; complete remissio
Keywords: مولتیپل میلوما; Bortezomib; Multiple myeloma; Proteasome activity; PSMB1; SNP;
Keywords: مولتیپل میلوما; Multiple myeloma; Differential scanning calorimetry; Serum protein electrophoresis; Thermodynamic parameters; Intercriteria analysis; Correlation analysis;
Keywords: مولتیپل میلوما; Multiple myeloma; Cancer; Elderly; Aging; Treatment; Geriatric assessment;
Keywords: مولتیپل میلوما; EBMT; European group for blood and marrow transplantation; MM; multiple myeloma; PRO; patient-reported outcome; QoL; quality of life; RRMM; relapsed and/or refractory multiple myeloma; VRS; verbal rating scales; Multiple myeloma; Relapse; Burden; Physicia
Keywords: مولتیپل میلوما; AREs; AU-rich elements; β2M; β2-microglobulin; GSs; gene expression signatures; GSEA; Gene-Set Enrichment Analysis; ISS; International Staging System; MM; multiple myeloma; MSigDB; Molecular Signatures Database; NF-ĸB; nuclear factor-kappa B; PI3K/Akt;
Keywords: مولتیپل میلوما; Multiple primary malignant neoplasms; Colorectal cancer; Multiple myeloma; Anemia;
Keywords: مولتیپل میلوما; Immunity; Infections; Monoclonal gammopathy of undetermined significance; Multiple myeloma; Vaccination;
Keywords: مولتیپل میلوما; multiple myeloma; treatment; diagnosis; supportive care; goals of treatment;
Keywords: مولتیپل میلوما; multiple myeloma; cytogenetics; microenvironment; staging;
Keywords: مولتیپل میلوما; AL; immunoglobulin light chain; CIDP; chronic inflammatory demyelinating polyradiculoneuropathy; CNDS; clinical neuropathy disability score; DADS-M; distal, acquired, demyelinating, symmetric neuropathy with M protein; INCAT; Inflammatory Neuropathy Cours